Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents
This Viewpoint explores how expectations influence outcomes of psychedelic drug therapy. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood
This cohort study assesses whether stimulant medication for attention-deficit/hyperactivity disorder is associated with later substance use after considering age and other confounding factors not previously studied. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

Childhood Maltreatment and Course of Emotional Disorders in Adulthood
This cohort study examined the relative associations of objective and subjective experiences of childhood maltreatment with the course of emotional disorders in adulthood. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

Investigating the Face Inversion Effect in Autism Across Behavioral and Neural Measures of Face Processing
This systematic review and meta-analysis explores differences of the face processing system in autism spectrum disorder, as measured by the face inversion effect, across multiple mechanistic levels. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

History of Substance Use Disorder and Health Outcomes —the Need for a Better Research Method to Determine Total Substance Use Exposure—Reply
In Reply We thank Christian et al for raising concerns that (1) chronic diseases, rather than substance use disorder (SUD), may be more directly responsible for adverse outcomes of COVID-19 infection and (2) SUD itself can cause chronic somatic and mental health disorders. Both concerns are valid and important. These suggest new directions for research to describe the relative impact of chronic diseases and SUD on outcomes of COVID-19 infection. We agree that a better understanding of how medications prescribed for opioid use disorder (eg, methadone or buprenorphine) alter COVID-19 risk among persons with this SUD would be...
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

Substance Use Disorder and Health Outcomes in COVID-19 —the Need for a Better Research Method to Determine Substance Use Exposure
To the Editor We were excited to read the article by Schieber and colleagues that describes an impressively large, retrospective, cross-sectional study demonstrating that among patients presenting to the emergency department who tested positive for COVID-19 infection, individuals with both psychiatric and substance use disorder (SUD) diagnoses had greater probability of hospitalization compared with either disorder alone or neither disorder. The authors briefly describe an important limitation of the study: that the exposure of SUD was determined based on International Statistical Classification of Diseases and Related Hea...
Source: JAMA Psychiatry - July 5, 2023 Category: Psychiatry Source Type: research

JAMA Psychiatry
Mission Statement:  JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians and researchers in psychiatry, mental health, behavioral science, and allied fields. The journal seeks to inform its readers, to stimulate discussion into the nature, causes, treatment, and public health importance of mental illness, and to promote equity and justice for those affected by mental illness and for society. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 1, 2023 Category: Psychiatry Source Type: research

Error in Table
In the article titled “Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths,” published online April 26, 2023, in JAMA Psychiatry, there was an error in the Table. The Masimo Wearable SafetyNet Alert device was mistakenly described as having no feature through which to alert em ergency medical services. The article has been corrected. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - July 1, 2023 Category: Psychiatry Source Type: research

Improving the Integration of Social Determinants of Mental Health in the DSM s
This Viewpoint discusses ways in which future editions of DSM could address social determinants in the diagnosis and treatment of mental health disorders. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Ambient Temperatures and the Prevalence of Intimate Partner Violence Among Women in South Asia
This cross-sectional study examines the association of ambient temperature with the prevalence of intimate partner violence among partnered women, aged 15 to 49 years, in low- and middle-income countries in South Asia and also projects the association of future climate warming with intimate partner violence. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at high Risk of Psychosis
This sequential multiple assignment randomized trial evaluates the efficacy of an intervention strategy for individuals at ultrahigh risk of psychosis. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Active Ingredients Within Internet-Delivered Cognitive Behavioral Therapy for Depression
This randomized clinical trial evaluates which specific components of internet-delivered cognitive behavioral therapy are active ingredients that reduce symptoms among patients with depression. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness
This randomized clinical trial investigates if an 18-month tobacco-smoking cessation intervention including weight management is effective in adults with serious mental illness who may not be ready to quit smoking right away. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Estimated Prevalence of Perinatal Depression in Low- and Middle-Income Countries Considering Uncertainty of Test Properties —Reply
In Reply We thank Pacheco and colleagues for their interest in our article. Most of the prevalence estimates we report in our systematic review and meta-analysis were derived from screening tools applied to large populations (most commonly the Edinburgh Postnatal Depression Scale). They present a subanalysis, recalculating the prevalence for depression where they account for the presumed screening performance of the Edinburgh Postnatal Depression Scale (ie, sensitivity and specificity), and they include a bayesian adjustment. (Source: JAMA Psychiatry)
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research

Estimated Prevalence of Perinatal Depression in Low- and Middle-Income Countries Considering Uncertainty of Test Properties
To the Editor The systematic review and meta-analysis conducted by Roddy Mitchell et al provides new evidence on the epidemiology of perinatal depression (PD) in low- and middle-income countries. The pooled prevalence of PD in this study was 24.7%. However, rates were higher in studies that used self-report screening tools (25.3%) compared with diagnostic interviews (17.8%). More than 90% of the studies used a self-report screening instrument, predominantly the Edinburgh Postnatal Depression Scale (EPDS), but none of them adjusted apparent prevalence estimates (the ones derived by applying thresholds of screening instrumen...
Source: JAMA Psychiatry - June 28, 2023 Category: Psychiatry Source Type: research